Exagen Inc. (XGN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Exagen Inc.

    NASDAQ: XGN · Real-Time Price · USD
    10.96
    0.07 (0.64%)
    At close: Oct 03, 2025, 3:59 PM
    10.70
    -2.37%
    After-hours: Oct 03, 2025, 07:12 PM EDT

    Exagen Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -15.12M -23.69M -47.39M -26.85M
    Depreciation & Amortization
    		 1.72M 2.17M 1.56M 948K
    Stock-Based Compensation
    		 1.76M 3.62M 4.7M 4.73M
    Other Working Capital
    		 -2.1M 732K -2.81M 1.34M
    Other Non-Cash Items
    		 1.43M 3.12M 7.62M 819K
    Deferred Income Tax
    		 n/a n/a -306K 148K
    Change in Working Capital
    		 -3.08M 325K 1.67M -61K
    Operating Cash Flow
    		 -13.28M -14.46M -32.14M -20.27M
    Capital Expenditures
    		 -515K -828K -4.32M -2.37M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 24K n/a -50K
    Investing Cash Flow
    		 -515K -804K -4.32M -2.42M
    Debt Repayment
    		 -861K -10.94M -696K -525K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a -239K -3.94M
    Financial Cash Flow
    		 -663K -10.63M -489K 64.68M
    Net Cash Flow
    		 -14.46M -25.9M -36.95M 41.99M
    Free Cash Flow
    		 -13.79M -15.29M -36.46M -22.64M

    Add to Watchlist